Abstract Cells are constantly under threat from the cytotoxic and mutagenic effects of DNA damaging agents. These agents can either be exogenous or formed within cells. Environmental DNA-damaging agents include UV light and ionizing radiation, as well as a variety of chemicals encountered in foodstuffs, or as air-and water-borne agents. Endogenous damaging agents include methylating species and the reactive oxygen species that arise during respiration. Although diverse responses are elicited in cells following DNA damage, this review focuses on three aspects: DNA repair mechanisms, cell cycle checkpoints, and apoptosis. Because the areas of nucleotide excision repair and mismatch repair have been covered extensively in recent reviews (1-6), we restrict our coverage of the DNA repair field to base excision repair and DNA double-strand break repair.
BASE EXCISION REPAIR
The major forms of DNA damage arising from the actions of endogenous agents are (a) hydrolytic depurination, (b) hydrolytic deamination of cytosine and 5-methylcytosine bases, (c) formation of covalent adducts with DNA, and (d ) oxidative damage to bases and to the phosphodiester backbone of DNA. The vast majority of these "small" lesions are repaired by the base excision repair (BER) pathway.
The BER pathway has been reviewed in detail elsewhere (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) and is depicted in Figure 1 . DNA glycosylases, of which there are several classes (see below), recognize abnormal DNA bases and catalyze hydrolytic cleavage of the N-glycosyl bond linking the base to the sugar. Following the generation of an apurinic/apyrimidinic (AP) site, in most cases the BER pathway can proceed utilizing a common set of proteins. The objective of the AP endonucleases and phosphodiesterases is to generate a single nucleotide gap containing 3 hydroxyl and 5 phosphate termini that permits a DNA polymerase to fill the gap. Finally, a DNA ligase can seal the remaining nick. Although this represents the primary pathway for BER, there are variations on the theme. First, instead of an AP endonuclease cleaving the phosphodiester backbone 5 to the AP site, some glycosylases remove the damaged base and cleave the phosphodiester backbone 3 to the resulting AP site via β-elimination (so-called AP lyases). In this case, the unsaturated sugar fragment left on the 3 site of the nick is removed by a phosphodiesterase to generate the necessary single nucleotide gap. One source of this phosphodiesterase action is a second activity exhibited by the AP endonuclease (17) (18) (19) (20) (21) . A second variation in BER is for the polymerization step of BER to involve a gap larger than one nucleotide (Figure 1 ). In this so-called "long-patch" pathway, approximately 2-10 nucleotides are excised and replaced by the combined actions of a DNA polymerase (usually Polδ or ε but possibly Polβ) proliferating cell nuclear antigen (PCNA), replication factor C (RF-C), and an endonuclease that cleaves "flap" structures (FEN-1) (22) (23) (24) (25) . The long-patch pathway seems to predominate when repair is initiated at oxidized or reduced AP sites generated by X-rays or chemical agents, whereas the single nucleotide gap repair pathway occurs when "regular" AP sites are generated. In the single nucleotide gap pathway the XRCC1 protein directs specific interactions with both Polβ and DNA ligase III (12, (26) (27) (28) (29) , and hence recruits this ligase to sites of ongoing repair. In long-patch BER the nick is probably sealed by DNA ligase I. Both branches of BER have been reconstituted in vitro (30) (31) (32) (33) .
The protein components of the BER pathway (see below) have been conserved both structurally and functionally during evolution, underscoring the vital role that BER plays in defending genome integrity. This role is further emphasized by the finding that disruption of BER function in mammalian cells is generally not compatible with viability. Thus, for example, mice deficient in HAP1 (34) and XRCC1 (35) die during embryonic development.
DNA Glycosylases for Repair of "Inappropriate" DNA Bases
Inappropriate bases include those not normally found in DNA, such as uracil, as well as normal bases found in the wrong context, such as thymine arising from deamination of 5-methyl cytosine. Uracil arises in DNA through deamination of cytosine residues, or through incorporation of dUTP during DNA replication. Uracil DNA glycosylase (UDG) excises uracil residues from DNA but not from RNA (7, 36) . Probably because of a requirement to efficiently distinguish between uracil and thymine in DNA, which are very similar in structure, UDG has little flexibility in its range of substrates, being limited to uracil and its derivatives such as 5 fluorouracil (7, 36) . Recent studies have provided a structural basis for this substrate specificity (37, 38) . Owing to the shape of the active site pocket, the target uracil nucleotide must adopt an extrahelical conformation. This "nucleotide flipping" mechanism is emerging as a conserved feature of the action of several BER enzymes. Human cells contain another UDG activity, designated hSMUG1, which prefers ssDNA containing uracil residues as a substrate (39) .
The DNA of many organisms, including man, includes cytosine residues methylated at the C 5 position. Upon deamination of 5-methylcytosine, thymine is generated in the context of a G:T mispair. Any repair system for correction of this mispair has two obvious requirements: The G:T mispair must be repaired to G:C, and thymine residues in A:T pairs must not serve as substrates. The glycosylase responsible for repair of G:T mispairs is thymine DNA glycosylase (40) . However, thymine DNA glycosylase is not specific for thymine residues, because it also recognises uracil when mispaired with guanine (41) . This "uracil glycosylase" activity has been conserved in organisms that do not methylate cytosine residues.
Glycosylases for Repair of Oxidized DNA Bases
Base oxidation in cellular DNA can arise following exposure to ionizing radiation, radiomimetic chemicals, and intracellular reactive oxygen species (ROS) (7) (8) (9) (10) (11) . In Escherichia coli oxidized purines are excised by the FPG protein (also known as MutM and FAPY glycosylase) (42) . FPG removes imidazole ring-opened derivatives, such as FAPY-guanine and FAPY-adenine and 7,8-dihydro-8 oxoguanine (8-OG) ( Figure 2 ) (7). 8-OG can mispair with A and therefore generates GC → TA transversion mutations. fpg mutants show an increased frequency of GC → TA mutations, consistent with a defect in 8-OG repair (7, 43, 44) .
Yeast and mammals contain proteins that perform roles analogous to those of FPG. The Saccharomyces cerevisiae Ogg1 protein has a substrate specificity similar to that of FPG, although their primary sequences are unrelated (45, 46). Instead, Ogg1 shows sequence similarity to the E. coli endonuclease (endo) III protein (see below). The human homolog of Ogg1 excises 8-OG paired with cytosine by flipping the 8-OG residue into an extrahelical configuration (47). The ability of Ogg1 to discriminate between 8-OG and guanine appears to be conferred by a single hydrogen bond between an active site glycine residue and the 8-OG moiety.
8-OG residues that have escaped repair prior to DNA replication can mispair with adenine. 8-OG:A mispairs are relatively poor substrates for Ogg1, presumably to exclude the use of the adenine residue as a template during DNA repair synthesis. All cells, therefore, express an enzyme that converts 8-OG:A mispairs to 8-OG:C through acting as an adenine glycosylase (48-50). The gene encoding this activity in E. coli is mutY (51-54). Because cells counteract 8-OG residues in DNA through the combined actions of FPG/Ogg1 and MutY, fpg mutY double mutants show an extremely high rate of GC → TA mutations (48). The MutY protein shows significant sequence similarity with E. coli endo III, including a conserved helixhairpin-helix (HhH) motif and cysteine residues that create a binding site for an iron-sulfur cluster of the (4Fe-4S) 2+ type (55). MutY is also conserved in evolution, and the human homolog, MYH, has a very similar substrate specificity to that of its bacterial counterpart (56, 57). Endo III excises numerous oxidation products of pyrimidines (7, (58) (59) (60) . Many substrates result from reaction of ROS at the 5,6-double bond, and include cytotoxic lesions such as thymine and cytosine glycols. However, endo III also recognizes ring-opened, ring-contraction and ring-fragmentation products of cytosine and thymine residues (Figure 3 ). Budding yeast express two endo III homologs, Ntg1 and Ntg2, the former of which lacks the characteristic iron-sulfur cluster (61, 62) . The substrate specificities of these two enzymes are similar but nevertheless different from that of endo III. The only known human endo III homolog, hNTH1, displays the major structural motifs (HhH and Fe-S cluster) found in endo III and has a substrate specificity similar to that of its bacterial counterpart (63, 64) .
Glycosylases for Repair of Alkylated Bases
A selection of the wide range of products of base alkylation is shown in Figure 4 . These adducts are repaired by a glycosylase designated 3-methyladenine DNA glycosylase (3-MAG) (reviewed in 7, 13). Two such enzymes, AlkA and Tag, exist in E. coli, the former being inducible as part of the adaptive response to DNA alkylation. A single major 3-MAG activity with a broad substrate specificity similar to that of AlkA exists in eukaryotes (7, 13) . 3-MAG also efficiently excises 1,N 6 -ethenoadenine (65). 3-MAG is important for repair of 3-methyladenine and 1,N 6 -ethenoadenine residues in vivo, and for the protection of mammalian cells against the cytotoxic effects of certain alkylating agents (66) (67) (68) . The ability of AlkA to recognize both positively charged and extended aromatic substrates derives from the presence of numerous aromatic side chains lining the catalytic cleft (69, 70) . The crystal structure of AlkA indicates a nucleotide flipping mechanism of action.
Alkylation at the O 6 position of guanine is potentially highly mutagenic because of the efficiency with which O 6 -alkylguanine mispairs with thymine, leading to GC → AT transition mutations. This lesion, which is also cytotoxic, is repaired by a conserved and specialized protein, O 6 -alkylguanine DNA alkyltransferase (O 6 -AT), reviewed elsewhere (71, 72) . The expression of O 6 -AT allows cells to resist the cytotoxic and mutagenic effects of a variety of alkylating agents, many of which are used in chemotherapy (71, 72) .
AP Endonucleases in BER
AP endonucleases counteract the cytotoxic and mutagenic potential of AP sites. These lesions arise via spontaneous hydrolysis of the N-glycosyl bond linking a base to the phosphodiester backbone, following damage to DNA by alkylating agents or ROS, and through the action of DNA glycosylases (7, 73) . There are two major families of AP endonucleases, termed the exonuclease (exo) III and endo IV families, which derive their name from the two AP endonucleases expressed in E. coli (7, 9, 11, 73) . In addition to AP endonuclease activity, these enzymes possess phosphodiesterase activity for removal of fragmented sugar residues, such as phosphoglycolate, from the 3 terminus of strand breaks induced by oxidants. This activity can also remove the 3 terminal groups left by AP lyases following β-elimination at AP sites (see above). AP lyase activity is a feature of the endo III and FPG families of glycosylases (7, 9, 11) .
The catalytic mechanism of action of both families of AP endonucleases has been revealed by X-ray crystallography. The human homolog of exo III, HAP1 (APE/Ref-1), shows structural similarity to DNase I (74) . The abasic deoxyribose lies in an extrahelical conformation and is stabilized in the HAP1 active site by interactions with specific residues (75) . Several active site residues required for the hydrolysis reaction have been identified by site-directed mutagenesis (17, 73, (76) (77) (78) (79) (80) . Structural studies of E. coli endo IV have revealed that both the abasic deoxyribose and its partner nucleotide are flipped out of the duplex (81) .
Structural and site-directed mutagenesis studies have suggested that HAP1 might coordinate different steps of the BER process through engaging in protein:protein interactions (12) . HAP1 interacts with and displaces glycosylases that are bound to the AP sites generated by their action. Moreover, following cleavage of the phosphodiester backbone, HAP1 remains bound to the nicked DNA until direct interactions with Polβ initiate the subsequent phosphodiesterase/ polymerization steps, helping to explain how BER can be such an efficient and rapid process in vivo.
Late Stages in BER
Polβ can catalyze both the 5 phosphodiesterase and polymerization steps in BER (Figure 1 ). Perhaps surprisingly, recent data using Polβ-deficient mouse cells indicate that only the phosphodiesterase action of Polβ is essential for protection against methyl methane sulfonate (82). As well as binding to a HAP1:DNA complex, Polβ makes interactions with the XRCC1 protein, which appears to play a scaffolding role in BER rather than any specific enzymatic function. XRCC1 then recruits DNA ligase III to sites of ongoing repair (83) .
DNA DOUBLE-STRAND BREAK REPAIR
DNA double-strand breaks (DSBs) arise in cellular DNA via a number of different routes, including exposure to ionizing radiation and radiomimetic chemicals, through the interaction of a replication fork with a single-stranded break in the template, and in a programmed manner during meiosis and immunoglobulin gene rearrangement (reviewed in 84, 85) . The three primary pathways for repair of DNA DSBs ( Figure 5 ) are discussed below.
Homologous Recombination
Knowledge of the mechanisms of homologous recombination (HR) and the protein components of the HR pathway has come primarily from genetic analyses in yeasts and subsequent biochemical studies. In S. cerevisiae HR is dependent upon the RAD52 epistasis group of genes, which includes RAD50, RAD51, RAD52, RAD54, RAD55, RAD57, RAD59, MRE11, and XRS2 (reviewed in 84, 86) . Rad51 is the eukaryotic homolog of E. coli RecA, which initiates HR through catalyzing homologous pairing and DNA strand exchange. Rad51 has a substantially reduced catalytic rate compared with RecA. To compensate for this apparent catalytic deficiency, eukaryotic Rad51 acts in concert with other proteins. Replication Protein A (RPA) enhances the efficiency of DNA strand-exchange reactions mediated by Rad51, but only if added to reactions after Rad51 has created the characteristic nucleoprotein filaments on ssDNA in which strand exchange occurs (87) (88) (89) (90) (91) . Rad52 and the Rad55/57 heterodimer both counteract the inhibitory effect of RPA, presumably by mediating exchange of Rad51 for RPA on ssDNA (87) (88) (89) (90) (91) . Moreover, Rad54 can stimulate Rad51-catalyzed pairing of homologous DNA molecules in vitro (92, 93) . Rad54 is a DNA-dependent ATPase of the Swi/Snf family whose precise role is unclear (94) . Several mammalian Rad55/57-related proteins have been identified, but whether any of these act as functional homologs remains unclear. Two of these, XRCC2 and XRCC3, were identified by functional complementation of X-ray-sensitive hamster cell mutants defective in DSB-induced HR (95) .
HR functions are vital for repair of DSBs (reviewed in [84] [85] [86] . In a recent model proposed by Van Dyck et al (96) Rad52 acts to initiate DSB repair through binding DNA ends. This binding protects DNA ends from exonucleolytic attack and facilitates end-to-end joining. Rad52 then loads Rad51 onto the DNA through direct protein:protein interaction. This end-binding function probably explains why Rad52 also acts during the single-strand annealing (SSA) pathway (see below). It is possible that Rad52 acts in partial competition with the Ku DNA end-joining complex to direct DSB repair down the HR pathway instead of the NHEJ pathway ( Figure 5 ).
In S. cerevisiae RAD52 is essential for DSB repair and HR (86) . However, RAD52 −/− mice are viable and fertile, and their cells do not display deficiency in DSB repair (97) . RAD54 −/− mice are also viable and fertile, despite having a cellular defect in the repair of DNA cross-links. These mice are hypersensitive to γ -rays at the embryonic, but not adult, stages (98, 99) . In contrast, RAD51 −/− mice die during early embryonic development.
The roles played by other DSB repair proteins are not fully elucidated. In yeast the Rad50/Mre11/Xrs2 complex provides nuclease activity and is implicated in DNA double-strand breaks generated by γ -rays or radiomimetic drugs are processed during either the nonhomologous end-joining (NHEJ) or the recombination-dependent pathways (right), possibly by competition between the Ku70/Ku80 complex and Rad52 for binding the ends. In NHEJ (left pathway) the Ku complex recruits DNA-PK cs and the XRCC4/ligase IV heterodimer to effect rejoining. In homologous recombination Rad51 is recruited by Rad52 to promote DNA strand invasion of an intact sister-chromatid or homologous chromosome. In single-strand annealing, resection and annealing of short complementary sequences precedes trimming of the noncomplementary ssDNA tails and ligation. resection of DSBs to create the 3 ssDNA tail necessary for Rad51 to initiate strand exchange (84) (85) (86) . Although the Rad50 and Mre11 proteins are highly conserved, Xrs2 is not. However, a protein with limited similarity to Xrs2, called NBS1 (or nibrin), appears to be the functional analog of Xrs2 (100-103). NBS1 has recently been shown to be the protein defective in the ataxia telangiectasia-like disorder, Nijmegen breakage syndrome.
HR is probably more complex in human cells than in yeasts. Two proteins that appear to play important roles in DSB repair are BRCA1 and BRCA2, both of which are tumor suppressor genes (104) . Mouse fibroblasts deficient in BRCA1 or BRCA2 show sensitivity to DNA-damaging agents and excessive chromosomal aberrations (105, 106) . BRCA1 and BRCA2 interact directly or indirectly with each other and with RAD51, providing a connection with HR (107) . A suggested role for BRCA1/2 is in transducing signals from factors that recognize DNA damage to the DNA repair machinery (see below).
Single-Strand Annealing (SSA)
SSA, like HR, is a process for rejoining DSBs using homology between the ends of the joined sequences ( Figure 5 ). However, SSA differs from HR in the manner in which this is achieved. The DNAs to be joined are first resected to generate ssDNA tails. When this resection has proceeded sufficiently to reveal complementary sequences, the two DNAs can than be annealed prior to DNA ligation. Inevitably, SSA has the potential to create deletions between repetitive sequences. SSA requires the Rad52 protein in S. cerevisiae but not Rad51, consistent with a lack of a requirement for DNA-strand invasion. The role for Rad52 is probably to bind the DNA ends and effect DNA annealing (84) (85) (86) .
SSA requires the Rad50, Mre11, Xrs2 protein complex in S. cerevisiae and the functionally analogous proteins in humans: RAD50, MRE11, and NBS1 (84) (85) (86) . It is likely that this complex is involved in the resection of DNA ends. After resection and annealing of complementary DNA sequences, the ssDNA tails must be trimmed ( Figure 5 ). This trimming is probably performed by the structure-specific XPF-ERCC1 endonuclease (Rad1/Rad10 in yeast) in human cells.
Nonhomologous End-Joining (NHEJ)
NHEJ is a process whereby dsDNA ends can be rejoined even where there is little or no base-pairing at the site of the junction. This pathway for DSB repair is apparently unique to eukaryotes. A conserved set of proteins, designated Ku70, Ku80, DNA ligase IV and XRCC4 in humans, is required for NHEJ ( Figure 5 ) (84) (85) (86) . In vertebrates the catalytic subunit of DNA-dependent protein kinase (DNA PK CS ) is also required (108). NHEJ is not only relevant to repair of dsDNA breaks induced by DNA damaging agents, but also to the processing of breaks arising during immunoglobulin gene rearrangement. Indeed, severe combined immune-deficiency in mice is associated with inactivation of DNA PK CS (108). Mice with a targeted disruption of the Ku80 gene show γ -ray sensitivity, a severe combined immunedeficiency phenotype, and an increase in chromosomal aberrations (109) (110) (111) (112) . In contrast, disruption of the XRCC4 or DNA ligase IV genes in mice leads to embryonic lethality (113) (114) (115) . Hence, deletion of the genes encoding DNA PK CS , Ku subunits or ligase IV reveals significant differences in phenotypes, suggesting that these proteins may play independent roles outside the NHEJ pathway. The XRCC4/ligase IV heterodimeric complex is recruited to DNA ends by the Ku complex (116) . NHEJ of linearized plasmid DNA has been achieved using cell free extracts (117) .
CELL CYCLE CHECKPOINTS ACTIVATED IN RESPONSE TO DNA DAMAGE
DNA repair is an important aspect of genomic maintenance whether or not cells are actively proliferating, but proliferation brings with it added complicating factors. Failure to complete repair before chromosomal replication or segregation can lead to fixation of mutations in the genome, or to irretrievable chromosome breakage. Genome integrity is therefore preserved in part by mechanisms that ensure that cell cycle progression is delayed until DNA damage is removed. These so-called checkpoint mechanisms can lead to cell cycle delay in the G1, G2, or S phase. Loosely analogous mechanisms may act to delay DNA replication in bacteria (118) , but this discussion is restricted to checkpoint controls in eukaryotes. Many checkpoint components are not required for cell cycle progression per se, but are brought into play specifically when DNA is damaged or replication blocked. In addition to their inhibitory cell cycle roles, several checkpoint components have functions related to activation of DNA repair, nucleotide metabolism, telomere maintenance, or induction of cell death.
Checkpoints were first defined through the identification of radiation-sensitive (rad) yeast mutants that fail to delay progression into mitosis after DNA damage (119) . Artificial imposition of cell cycle arrest, for example by the use of spindle poisons, can be sufficient to correct the DNA-damage sensitivity of checkpoint mutants, underlining the importance of this delay for cell survival. Genetic screens in the yeasts S. cerevisiae and Schizosaccharomyces pombe have defined the pathways linking checkpoint gene products, and these interactions are increasingly being clarified at the biochemical level (120, 121) . In general, the radiation sensitivity of checkpoint mutants parallels sensitivity to other agents inducing DNA double-strand breaks or forming DNA adducts, though the defects in some mutant strains are lesion specific.
Mec1/Rad3/ATM/ATR Activation: A Fundamental Eukaryotic Checkpoint Response to DNA Damage
Checkpoint genes functionally related to those identified in yeast model systems have been identified in multicellular organisms through analysis of mutants sensitive to radiation and by sequence database searches. Although the corresponding checkpoint pathways in various eukaryotic species differ in their detail, their overall organization is conserved ( Table 1) .
Many of the checkpoint determinants defined genetically have been found to be phosphoproteins and/or protein kinases. Prominent among these are members of a family of large kinases including S. cerevisiae Mec1, S. pombe Rad3, and the human proteins ATM and ATR. These proteins belong to the phosphoinositide 3-kinase superfamily, but phosphorylate protein substrates rather than lipids. Each is activated in response to DNA damage, and a number of phosphorylation events have been identified that are dependent on activation of these kinases. On this basis, the Mec1/Rad3/ATM/ATR family is thought to act early in the checkpoint pathway, either as DNA-damage detectors or in close association with such detectors. In mammalian cells, these kinases are activated in a somewhat lesion-specific fashion, with ATM being specific for agents that induce DNA, DSB, and ATR, probably responding to UV-induced damage (122) . In contrast, the yeast members of the family are activated in response to a wide variety of DNA structures, including stalled replication forks.
Additional conserved checkpoint components that function in concert with the Mec1/Rad3/ATM/ATR kinases have been identified. In S. pombe these include the "checkpoint Rad" proteins Rad1, Rad9Sp, Rad17Sp, Rad 26, and Hus1, loss of any one of which confers radiation sensitivity and checkpoint defects very similar to those seen in cells lacking Rad3. Double mutants combining defects in any two of the checkpoint rad genes have phenotypes indistinguishable from the corresponding single mutants, suggesting that all of these gene products act in a common pathway.
Many of the checkpoint Rad proteins display low level, but significant, similarity to proteins involved in DNA replication. Specifically, Rad1, Rad9Sp, and Hus1 are related to the DNA polymerase accessory protein PCNA, whereas Rad17Sp is related to subunits of RF-C. These sequence similarities are reflected in physical associations, as Rad1, Rad9Sp, and Hus1 are found together in a complex (123, 124) , as are their equivalents in S. cerevisiae (125) and human cells (126) , whereas Rad17Sp (like Rad24, its equivalent in S. cerevisiae) is associated with authentic RF-C subunits on chromatin (127, 128) . During DNA replication RF-C functions to load PCNA onto chromatin. By analogy, it might be expected that Rad17Sp, in association with conventional RF-C subunits, might load the Rad1/Rad9Sp/Hus1 complex onto DNA in response to DNA damage. Just as PCNA acts by tethering replicative polymerases to their template, Rad1/ Rad9Sp/Hus1 could form a sliding clamp, which has the dual purpose of checkpoint signaling and recruiting DNA repair enzymes (129) . Additional evidence supporting this model has come from studies of temperature-sensitive mutants with defects in RF-C subunits. Such mutants not only fail to suppress mitosis during DNA replication, but also display sensitivity to DNA-damaging agents, associated with loss of checkpoint control (127, 130) . In human cells hRAD17 is localized to the nucleolus and redistributed to the nucleoplasm following UV irradiation (131) , but the significance of this potential mode of regulation has yet to be established.
A straightforward checkpoint pathway model would comprise damage detectors, signal transducers and cell cycle inhibitory effector mechanisms, but this type of linear representation may not be adequate to explain all of the experimental observations relating to Mec1/Rad3/ATM/ATR and the other checkpoint Rad proteins. For example, studies in S. cerevisiae using damage in the form of single-stranded DNA near telomeres, induced by a defect in the Cdc13 protein, place Mec1 downstream from Rad17Sc, Rad24, Mec3, and the checkpoint determinant Rad9Sc (132) . These studies have given rise to an alternative view of the DNA-damage checkpoint pathway, in which Rad17Sc, Rad24, and Mec3 serve to activate an exonuclease (perhaps Rad17Sc itself ). This nuclease processes primary lesions in a manner that leads to the generation of a checkpoint signal. Conversely, protein phosphorylation studies suggest that Rad9Sc acts downstream from Mec1 (133, 134) . Similarly, Rhp9/Crb2, the Rad9Sc analogue in S. pombe, appears to act downstream from Rad3 (135, 136) , and DNA damage-induced, Rad3-dependent phosphorylation of Rad26 is independent of all other known checkpoint proteins (136) . It has been suggested that some of these phosphorylation events could reflect the activation of feedback controls, rather than the transmission of the checkpoint signal itself (137) ; hence, an all-embracing model describing the order in which these checkpoint components act is still elusive.
Effectors of the Checkpoint Rad Pathway
Checkpoint signaling downstream from Mec1/Rad3/ATM/ATR and the other checkpoint Rad proteins is focused on serine/threonine protein kinases typified by the yeast proteins Chk1 and Rad53/Cds1, and their equivalents in vertebrates, CHK1 and CDS1/CHK2. The positioning of these kinases downstream from the checkpoint Rad proteins reflects the fact that Chk1 overexpression can partially suppress the DNA-damage sensitivity of checkpoint rad mutants (138) , and that Chk1, Cds1, CHK2, or Rad53 activation after DNA damage is checkpoint Rad dependent (139) (140) (141) (142) . The detailed requirements for activation of these kinases, and the consequences of their inactivation, differ within and between species. Chk1 mutants are radiation sensitive in S. pombe, but not in S. cerevisiae (143) , where the Cds1-like kinase, Rad53, assumes a major checkpoint signaling role after DNA damage. Conversely, in fission yeast Cds1 is activated specifically during S phase, and is required for S-phase retardation in response to DNA damage (141), but cds1 mutants are not appreciably radiation sensitive.
A variety of mechanisms have been identified downstream from these Ser/Thr kinases that can transduce checkpoint signals to cell cycle effector proteins. In fission yeast and human cells the key mitotic cyclin-dependent kinase, Cdc2, is a principal target of the checkpoint pathway activated in response to DNA damage or inhibition of replication. Cdc2-cyclin B heterodimers act to trigger all the major events of mitosis (144, 145) , and inhibition of this protein kinase is sufficient to prevent mitotic entry. Inhibition of Cdc2-cyclin B in response to checkpoint activation is associated with phosphorylation of the Cdc2 subunit at inhibitory residues Thr14 and/or Tyr15 (reviewed in 121). Phosphorylation at these sites is carried out principally by the Wee1 protein kinase, with secondary activities attributable to the kinases Mik1 and Myt1 in S. pombe and human cells, respectively. These cell cycle inhibitory kinases are counterbalanced by the Cdc25 protein phosphatase, which activates Cdc2 by removing phosphate from Tyr15. An abrupt switch between interphase and mitosis is ensured by positive feedback mechanisms, through which active Cdc2 serves both to inhibit Wee1 and to activate Cdc25. During the checkpoint response to DNA damage, activation of Chk1 or Cds1 has the opposite effect. These kinases phosphorylate Cdc25 on Ser216, generating a recognition signal for 14-3-3 proteins, which sequester Cdc25 in the cytoplasm (Figure 6 ). The biological activity of Wee1 may also be increased by Chk1-mediated phosphorylation, and both Wee1 and Mik1 are stabilized in a Chk1-dependent manner (146, 147) . The importance of these mechanisms that converge on Thr14/Tyr15 phosphorylation of Cdc2 is underlined by the checkpoint-defective phenotypes induced in S. pombe or human cells by mutant Cdc2 proteins lacking these phosphorylation sites (148, 149) .
In S. cerevisiae inhibition of Cdc28, the Cdc2 homolog, is not a significant feature of the DNA-damage checkpoint, which instead operates to block onset of mitotic anaphase as well as exit from mitosis (143) . These effects are respectively brought about through the Chk1-dependent stabilization of the Pds1 sister chromatid cohesion protein and the Rad53-dependent inhibition of the Cdc5 protein kinase. Analogous mechanisms may operate in other organisms, but are perhaps masked by the Cdc2 pathway, which leads to arrest at an earlier stage in the cell cycle.
The BRCA1 tumor suppressor protein is a substrate of both ATM and CHK2 (150, 151) , and BRCA1 mutant cells are defective in DNA damage-induced G2 arrest (152), possibly because they fail to downregulate cyclin B transcription (153) . Mutated forms of BRCA1 lacking sites of ATM/CHK2-dependent phosphorylation are unable to reverse the radiation hypersensitivity of BRCA1-deficient cell lines, suggesting that these phosphorylation events are indeed involved in transduction of the checkpoint signal.
A number of observations suggest a significant link between the DNA damage checkpoint and telomere maintenance. Telomere shortening has been observed in ATM −/− (154) and checkpoint rad mutants (155) (156) (157) . Furthermore, the Tel1 protein, which is principally concerned with telomere maintenance, can partially compensate for loss of Mec1 (144, 158) . However, there is a functional distinction between DNA damage checkpoint and telomere maintenance functions of checkpoint Rad proteins in S. pombe, as the latter function does not require Chk1 or Cds1 (155) . The telomere maintenance function may, therefore, be the evolutionary precursor from which the DNA-damage checkpoint mechanism was derived.
Slowing of DNA replication in response to DNA DSB is checkpoint Rad and Rad53/Cds1 dependent in yeasts (159, 160) and ATM dependent in human cells (161) , but the effector mechanism(s) in this case are not clearly understood. NBS1 is phosphorylated by ATM and may act downstream in this pathway (162) (163) (164) . The involvement of NBS1 in the S-phase damage checkpoint may be secondary to its principal role in DNA repair, as discussed above. NBS1, like Xrs2, its functional counterpart in budding yeast, is associated with MRE11 and RAD50, which are required both for DSB repair and for telomere maintenance (165, 166) . The overlap between checkpoint controls, DNA repair, and telomere maintenance is therefore extensive.
Damage Tolerance and Cell Cycle Resumption
In yeasts protracted failure to repair DNA damage can be followed by cell cycle re-entry in the presence of persistent DNA strand breaks (167, 168) . Cell cycle resumption under these circumstances requires Ku70, in the absence of which residual breaks are subject to 5 to 3 degradation. Tolerance of DNA strand breaks necessarily involves the suppression of cell cycle arrest; ssDNA generated in the absence of Ku70 presumably triggers a checkpoint signal that cannot be suppressed in this way. In line with this interpretation, mutations in Mre11 or Rad50, which reduce the extent of ssDNA generation, also suppress the permanent arrest seen after damage in Ku70 mutants. In S. pombe, cell cycle restart after arrest at the DNA-damage checkpoint requires phosphorylation of Crb2 by Cdc2 (169), but it is not yet clear whether analogous mechanisms operate in more complex organisms.
Cell Cycle Checkpoint Roles of p53
DNA-damage checkpoints in higher eukaryotes have acquired additional levels of complexity not found in yeast cells. The tetrameric transcription factor and tumor suppressor p53 is central to these higher eukaryotic checkpoint controls. The requirement for p53 in DNA damage-induced G1 arrest is largely, though not completely, explicable in terms of transcriptional induction of the cyclin-dependent kinase inhibitor p21
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, which binds to and inhibits G1 cyclin-dependent kinases. This mode of cell cycle arrest can range from transient to very protracted depending on the cell type concerned (170) . Activation of p53 in response to DNA damage and other stresses involves complex posttranslational modification of p53 and its negative modulator MDM-2, which is itself induced by p53 at the transcriptional level. MDM-2 targets p53 for proteolysis by the ubiquitin/proteasome pathway (171) , and downregulation of this proteolytic pathway following DNA damage allows p53 accumulation.
Activation of p53 also contributes to DNA damage-induced G2 arrest, through the increased expression of both 14-3-3σ , which sequesters Cdc2-cyclin B heterodimers in the cytoplasm, and p21
, which can inhibit Cdc2 (172-175) . Transcription of the genes encoding CDC2 and cyclin B can also be repressed in a p53-dependent manner (176) (177) (178) . These p53-dependent mechanisms act in parallel with the checkpoint Rad pathway. Cells lacking functional p53 are therefore wholly reliant on the checkpoint Rad proteins and exhibit a less robust damageinduced G2 arrest than do cells with functional p53. Because p53 function is lost by one means or another in a large proportion of many tumor types, it may be possible to exploit this generality by using DNA damaging agents in combination with drugs that inactivate the already weakened checkpoint responses of p53-compromised cells. Checkpoint-inhibitory drugs with these properties include staurosporines, which can inhibit Chk1 (179), and caffeine, which probably targets Mec1/Rad3/ATM/ATR (180, 181) .
Regulation of p53 Following DNA Damage
The p53 pathway has arisen relatively recently during eukaryotic evolution and appears to have taken advantage of the pre-existing checkpoint Rad DNA damage signaling pathway (Figure 7 ). Human p53 is phosphorylated at serine residues 15, 20, 33, and 37 in response to DNA damage (reviewed in 182), potentially modulating its interaction with MDM-2. Stabilization of p53 and its phosphorylation at Ser15 following DNA DSB are ATM dependent, whereas following UV irradiation, Ser15 phosphorylation of p53 is ATM independent and can be blocked by expression of a dominant negative form of ATR. Phosphorylation at Ser15 and Ser37 may promote the interaction of p53 with the TFIID transcription factor. However, recent evidence suggests that phosphorylation at Ser20 is more significant for p53 stabilization (183) . CHK1 and CHK2 phosphorylate p53 at Ser20, and the ATM/ATR-dependent activation of these kinases partly explains the requirement for ATM/ATR in p53 stabilization (183, 184) . In line with this interpretation, cells lacking CHK2 are defective for p53 stabilization (185) , and germ-line mutations in CHK2 can give rise to Li-Fraumeni syndrome, a cancerprone disorder that can also be caused by germ-line mutations in the TP53 gene encoding p53 (186) . ATM-dependent phosphorylation of MDM-2 also modulates the p53-MDM-2 interaction and hence contributes to DNA damage-induced p53 stabilization (187) .
Additional DNA damage-induced posttranslational modifications of p53 occur in the C-terminal region, which modulates the sequence-specific DNA-binding activity of the protein. Phosphorylation of Ser392 stimulates this activity and is induced by UV but not by ionizing radiation (188) . Ser376 and Ser378 are phosphorylated in unirradiated cells, but IR induces rapid and ATM-dependent dephosphorylation of Ser376. This unmasks a site to which 14-3-3 proteins bind, leading to elevated sequence-specific DNA binding by p53. ATM is presumed to activate the phosphatase that acts on Ser376.
p53 is modified by acetylation on Lys320 by the PCAF acetyl transferase after exposure of cells to UV, and on Lys373 and Lys382 by p300/CBP in response to both IR and UV (189, 190) . Acetylation of these residues activates sequencespecific DNA-binding activity of p53 in vitro. Significantly, p53 that is phosphorylated either on Ser15 or on both Ser33 and Ser37 is a preferred substrate for p300/CBP, whereas phosphorylation at Ser378 strongly inhibits acetylation by PCAF (190) . Hence, DNA damage-induced modifications of p53 are carefully coordinated and interdependent.
Checkpoint Controls and DNA Repair: Further Connections
Activation of the DNA-damage checkpoint in S. cerevisiae leads to the transcriptional induction of a number of genes encoding DNA repair proteins. This pathway requires the Dun1 protein kinase in addition to Mec1 and Rad53 (120) . Related mechanisms are likely to operate in other eukaryotes and may help explain experimental observations that suggest a role for ATM in DNA repair by NHEJ (191) .
ATM was recently found to be a component of a very large complex that also contains BRCA1, MRE11/RAD50/NBS1, the BLM helicase, MSH2, MSH6, MLH1, and RF-C (192) . This complex is potentially involved in the recognition of diverse abnormal DNA structures, in the transmission of checkpoint signals, and in various aspects of DNA repair itself. When a more comprehensive overview of these processes becomes available, the boundaries between them are likely to be rather indistinct.
CELL DEATH
As an alternative to DNA repair or damage tolerance, multicellular eukaryotes have at their disposal a dramatic strategy for dealing with DNA damage, namely the engagement of the apoptotic cell death pathway. Although this is often viewed as a mechanism for eliminating irreparably damaged cells that might otherwise threaten the health of the organism, the threshold level of damage required to trigger apoptosis is highly cell type-dependent. Levels of damage sufficient to induce rapid apoptosis in thymocytes, for example, induce cell cycle arrest followed by apparently complete repair in other cell lineages. Apoptosis induced by DNA damage is indistinguishable at the cellular level from genetically programmed cell death that occurs during the development of a variety of tissues. Characteristic alterations seen in both cases include cell rounding, plasma membrane blebbing, peripheral condensation of the nuclear DNA without disassembly of the nuclear envelope, and internucleosomal DNA cleavage. These changes distinguish apoptosis from necrotic cell death, which can also result from DNA damage but is not viewed as an active cellular response and is therefore not discussed here.
The events of apoptosis are brought about by activation of members of a specialized family of cysteine aspartyl proteases, the caspases (reviewed in 193). The importance of these enzymes was first revealed by genetic studies of C. elegans, which showed that the caspase product of the ced-3 gene is essential for developmentally regulated apoptosis. Similarly, specific inhibition of caspases in mammalian cells is sufficient to block the morphological aspects of apoptosis and delay cell death. Active caspases are heterodimeric, consisting of large and small subunits generated by caspase-mediated cleavage of a common procaspase precursor protein; there is therefore the potential for amplification of apoptotic signals through caspase cascades. In human cells caspases 8 and 9 play key regulatory roles in these cascades, whereas other members of the family perform effector roles downstream (Figure 8 ). In some cases release of cytochrome c from mitochondria appears to be an early step in caspase 9 activation. Cytochrome c release stimulates the human APAF-1 protein, a structural relative of the pro-apoptotic CED-4 protein in C. elegans, to bind and activate procaspase 9.
BCL-2 is the prototypical member of a second family of proteins with important functions in the regulation of apoptosis. A BCL-2 homologue in C. elegans is encoded by the ced-9 gene and functions as a suppressor of CED-3-mediated cell deaths. Additional BCL-2-related proteins in mammals have roles in either the promotion or the inhibition of apoptosis. Members of the BCL-2 family are capable of forming homo-and heterodimers, and probably function primarily as regulators of caspase activation, in part by governing mitochondrial cytochrome c release.
Receptor-Mediated Cell Death
Aside from DNA damage, other physiologically important triggers of apoptosis include growth factor withdrawal, depletion of nucleotide pools, and engagement of transmembrane "death receptors" of the tumor necrosis factor (TNF) receptor superfamily. The best-characterized members of this family are FAS (also known as CD95 or APO1) and the TNF receptor (TNFR1) itself, the intracellular domains of which share a common structure termed the "death domain." The pro-apoptotic ligands for these receptors are homotrimeric peptides that are either soluble or expressed at the surface of adjacent cells. Ligand-induced receptor clustering promotes the binding of a soluble cytosolic adapter protein called FADD, which in turn mediates caspase 8 activation. Perhaps surprisingly, DNA damage-induced apoptosis can be FAS-and FAS ligand-dependent (194) (195) (196) . Thus, a death signaling pathway presumed to be initiated by DNA damage in the nucleus can include extracellular components. This aspect of apoptotic signaling may help explain "bystander" effects, whereby undamaged cells adjacent to those exposed to DNA-damaging agents are also susceptible to apoptotic stimuli (197) .
p53-Dependent and p53-Independent Apoptosis
In addition to its cell cycle regulatory functions, p53 is absolutely required for some forms of apoptosis, such as DNA damage-induced thymocyte death in vivo (198) . The degree to which p53 is activated can be central to the cellular decision of whether to arrest the cell cycle or to initiate cell death after exposure to DNA damage or other stresses (199) . Potential mechanisms for this pro-apoptotic effect include p53-mediated transcriptional induction of FAS (195) , or of BAX and NOXA, which encode pro-apoptotic members of the BCL-2 family (200) (201) (202) . Induction by p53 of the transcription factor NF-κB may also be a significant death-promoting pathway (203) , and a nontranscriptional apoptotic function for p53 has also been proposed (204) .
The extent of DNA damage can influence the extent of subsequent apoptosis without altering p53 levels, and some forms of apoptosis are p53-independent (198, 205, 206) . In some such cases, apoptosis results from induction of the FAS ligand through the activation of the transcription factor AP-1, via the c-Jun N-terminal kinase (207, 208) . Activation of AP-1 and NF-κB, like activation of p53, is not necessarily pro-apoptotic, however, and in some circumstances each can instead act to delay or block cell death (209, 210) .
COORDINATING CELL CYCLE CONTROLS, DNA REPAIR, AND APOPTOSIS
DNA damage-induced apoptosis can be initiated from any point in the cell cycle, as well as from a quiescent [G0] state. There is therefore no obligatory connection between cell cycle regulators and the molecules responsible for the onset of apoptosis. Several experimental observations nonetheless suggest that apoptosis can be triggered by resumption of cycling in cells that have previously been arrested at the G2 checkpoint following DNA damage (see, for example, 211). Progression into mitosis with DNA strand breaks could generate secondary damage capable of triggering a powerful apoptotic stimulus. In normal epithelial cells DNA-damage-induced, p53-independent apoptosis has delayed kinetics in comparison with p53-dependent death (212) . This delay could reflect a requirement for cell cycle progression and/or lesion processing in p53-independent apoptotic induction.
As discussed above, the checkpoint Rad pathway is a primordial eukaryotic DNA-damage response to which additional effector mechanisms have been added during the course of evolution. This applies not only to p53, but also to other apoptotic regulators. For example, in human cells hRAD9 interacts with BCL-2 in a manner that appears to promote apoptosis (213) . Enforced expression of BRCA1, which may recapitulate some aspects of the DNA-damage response routed through ATM, leads to c-Jun N-terminal kinase-dependent apoptosis (214) . Furthermore MRT-2, the Rad1 homolog in C. elegans, is required for DNA damage-induced apoptosis as well as cell cycle arrest (215) . The extent to which activation of the checkpoint Rad pathway is involved in the human p53-dependent and p53-independent apoptotic pathways outlined above awaits further clarification.
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